NSC |
Compound |
Enrichment |
Correlation |
NSC 315844 |
2(1H)-Pyrimidinone, 1-(2,5-dihydro-5-oxo-2-furanyl)-5-fluoro-4-methoxy- |
0.0314734733353265 |
0.5878794 |
NSC 31709 |
Quinolinium, 2-[2-(2,5-dimethyl-1-pentyl-1H-pyrrol-3-yl)ethenyl]-1,6-dimethyl-, chloride |
0.0314734733353265 |
0.27995709 |
NSC 371488 |
9-(3,4-dichlorophenyl)-2,7-bis((dimethylamino)methyl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione, dihydrochloride |
0.0314734733353265 |
0.28799506 |
NSC 46401 |
.alpha.-Sarcin |
0.0314734733353265 |
-0.073011217 |
NSC 58906 |
9H-Purine, 6-[(o-chlorobenzyl)thio]-9-(2-chloroethyl)- (8CI) |
0.0314734733353265 |
0.2060248 |
NSC 59220 |
[[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt |
0.0314734733353265 |
0.13718082 |
NSC 603831 |
Acteoside |
0.0314734733353265 |
0.26039516 |
NSC 622341 |
Null |
0.0314734733353265 |
0.714354 |
NSC 624233 |
Null |
0.0314734733353265 |
0.36822115 |
NSC 624659 |
ANTINEOPLASTIC-624659 |
0.0314734733353265 |
0.61548102 |